Test Price
2,800 AED✅ Home Collection Available
MDM2 Gene (Accelerated Tumor Formation Susceptibility) Genetic Test in Dubai, UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% Analytical Sensitivity via ISO 15189:2022 accredited NGS platform, validated against DHA standards.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post-test consultation with a DHA-licensed Consultant Medical Geneticist to interpret results.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
UAE DHA Licensed Facility 1143 | ISO 15189:2022 | Compliant with Federal Decree-Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019.
Test Overview & Methodology
The MDM2 gene NGS test identifies germline and somatic variants linked to accelerated tumor formation, enabling precise cancer risk stratification and proactive clinical management. This test is essential for patients with a personal or family history of hematologic or solid organ malignancies and guides personalized screening protocols.
| Feature | Our Test (DHA-Compliant) | Closest Alternative |
|---|---|---|
| Methodology | Full-gene NGS with CNV analysis, 1000x coverage | Single-gene Sanger sequencing (limited variants) |
| Turnaround Time | 21–28 calendar days | 4–6 weeks |
| Clinical Reporting | Interpreted by Consultant Medical Geneticist, DHA-licensed | Standard variant listing without clinical correlation |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist (DHA ID: 9294403), I emphasize that MDM2 genetic testing is a powerful predictive tool but must always be correlated with comprehensive clinical evaluation by a multidisciplinary team including an oncologist, hematologist, and genetic counsellor. A positive variant does not guarantee cancer onset; it stratifies risk and guides intensified surveillance.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics
Pre-Test Genetic Counselling Requirement
Mandatory Session
Before sample collection, a mandatory genetic counselling session with a certified genetic counsellor is required to document a detailed pedigree chart and obtain informed consent, ensuring full compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Safety Exclusion Criteria & Red Flags
- Exclusion: Patients with severe hemophilia or active bleeding disorders—contact the lab for specialized collection protocols.
- Exclusion: Inability to provide informed consent without a legal guardian present.
- Red Flag: If experiencing sudden, unexplained weight loss, persistent fevers, or night sweats, seek immediate medical evaluation before genetic testing.
- Red Flag: A positive result for a pathogenic variant should trigger urgent oncologic consultation within 7 days.
Patient FAQ & Clinical Guidance
1. What does the MDM2 gene test detect, and why is it important for cancer risk assessment?
The MDM2 NGS test identifies inherited and acquired mutations in the MDM2 gene that can lead to uncontrolled cell growth and accelerated tumor formation, enabling early cancer prevention strategies and personalized surveillance.
2. Is genetic testing for the MDM2 gene permitted for minors under 18 in the UAE?
Yes, federal law permits predictive genetic testing for minors only with explicit parental consent and a mandatory documented genetic counselling session, fully compliant with UAE data protection and pediatric care regulations.
3. How accurate is the MDM2 genetic test, and what do the results indicate?
With >99.9% analytical sensitivity and specificity, a pathogenic MDM2 variant indicates an elevated lifetime cancer risk that should be managed through intensified surveillance, lifestyle modifications, and family screening.
UAE Regulatory & Data Privacy Adherence
Data Privacy and Confidentiality Assurance
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access-controlled, and processed under the stringent oversight of the Dubai Health Authority (DHA License No. 1143).
Clinical & Logistical Metadata
| Test Name | MDM2 Gene (Accelerated Tumor Formation Susceptibility) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 Calendar Days |
| Sample Type / Matrix | Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA (≥1 µg) |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | Z15.09 (Susceptibility to other malignant neoplasm) |
| LOINC Code | 90542-4 (MDM2 gene mutation analysis) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians